HPV & cervix neoplasia in a large, long-term HIV+ cohort

HPV病毒

基本信息

  • 批准号:
    7068151
  • 负责人:
  • 金额:
    $ 72.37万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2000
  • 资助国家:
    美国
  • 起止时间:
    2000-01-15 至 2010-04-30
  • 项目状态:
    已结题

项目摘要

Women with HIV/AIDS are at high risk of cervical cancer, and have high rates of infection with human papillomavirus (HPV), the viral cause of cervical cancer. Through the semiannual evaluation of 2,793 HIV+and 975 HIV- women enrolled in the Women's Interagency HIV Study (WIHS), a multicenter cohort, the "WIHS HPV Investigation" is intended to be the definitive study of the effects of HIV coinfection on HPV and cervical dysplasia. This application seeks support for continuation of HPV research in the WIHS. The proposed project will be the first systematic effort to study type-specific differences in the effects of host immune status on HPV natural history in HIV+ women. Our recent results showed that HPV 16, the type that accounts for half of all cervical cancers, was the least affected by immune status (CD4+ count) of any HPV type. Two HPV types related to HPV 16 were also weakly associated with CD4+. Other HPVs, however, have not been adequately characterized, nor could we previously address the strong interaction between the effects of plasma HIV RNA and CD4+ count. Continuation of the WIHS HPV Investigation will provide the needed statistical power to examine HPV type-specific results by combined plasma HIV RNA/CD4+ strata, and it will generate the only truly long term prospective data regarding HPV infection in HIV+ women -valuable data in an era in which women can live for years with HIV. This application also represents an important opportunity to study local cervical HIV levels and their effects on HPV infection. It is known that there is substantial compartmentalization of HIV in the genital tract, but whether cervical HIV RNA levels are independently or, compared with plasma levels, more strongly associated with HPV has not been determined. Finally, once infection with an oncogenic HPV is established it remains unclear what role immune status plays in progression to severe cervical dysplasia. Continued follow-up in the WIHS will, for the first time, make it possible to prospectively study the risk factors for severe cervical dysplasia (a true cancer precursor) in HIV+ women. In summary, the aims are to study: (i) type-specific differences in the effects of host immune status on HPV natural history; (ii) the relationship between cervical HIV RNA levels and HPV infection; (iii) risk factors for progression to severe cervical dysplasia in HIV+ women.
感染艾滋病毒/艾滋病的妇女患宫颈癌的风险很高,感染人乳头瘤病毒(HPV)的比率很高,HPV是宫颈癌的病毒原因。通过对2,793名HIV阳性和975名HIV阴性妇女进行半年一次的评估,这些妇女参加了妇女机构间HIV研究(WIHS),这是一个多中心队列,“WIHS HPV调查”旨在成为HIV合并感染对HPV和宫颈发育不良影响的确定性研究。本申请寻求对WIHS继续进行HPV研究的支持。拟议的项目将是第一个系统性研究宿主免疫状态对HIV+女性HPV自然史影响的类型特异性差异的努力。我们最近的研究结果表明,HPV 16型占所有宫颈癌的一半,受任何HPV类型的免疫状态(CD 4+计数)的影响最小。与HPV 16相关的两种HPV类型也与CD 4+弱相关。然而,其他HPV尚未得到充分表征,我们以前也无法解决血浆HIV RNA和CD 4+计数之间的相互作用。WIHS HPV调查的继续将提供所需的统计功效,以通过合并血浆HIV RNA/CD 4+分层检查HPV类型特异性结果,并且它将生成关于HIV+女性HPV感染的唯一真正长期前瞻性数据-在女性可以携带HIV多年的时代有价值的数据。这项应用也是研究当地宫颈HIV水平及其对HPV感染影响的重要机会。众所周知,生殖道中存在大量的HIV区室化,但宫颈HIV RNA水平是否与HPV独立相关,或与血浆水平相比,与HPV的相关性更强,尚未确定。最后,一旦确定感染了致癌HPV,免疫状态在严重宫颈不典型增生的进展中起什么作用仍不清楚。WIHS的持续随访将首次使人们有可能前瞻性地研究艾滋病毒阳性妇女严重宫颈发育不良(一种真正的癌症前兆)的风险因素。总之,目的是研究:(i)宿主免疫状态对HPV自然史影响的类型特异性差异;(ii)宫颈HIV RNA水平与HPV感染之间的关系;(iii)HIV+妇女进展为严重宫颈发育不良的风险因素。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HOWARD D STRICKLER其他文献

HOWARD D STRICKLER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HOWARD D STRICKLER', 18)}}的其他基金

Molecular Methods to Improve Cervical Cancer Screening in HIV+ Women
改善艾滋病毒女性宫颈癌筛查的分子方法
  • 批准号:
    9037614
  • 财政年份:
    2013
  • 资助金额:
    $ 72.37万
  • 项目类别:
Molecular Methods to Improve Cervical Cancer Screening in HIV+ Women
改善艾滋病毒女性宫颈癌筛查的分子方法
  • 批准号:
    9122798
  • 财政年份:
    2013
  • 资助金额:
    $ 72.37万
  • 项目类别:
Molecular Methods to Improve Cervical Cancer Screening in HIV+ Women
改善艾滋病毒女性宫颈癌筛查的分子方法
  • 批准号:
    8825466
  • 财政年份:
    2013
  • 资助金额:
    $ 72.37万
  • 项目类别:
Molecular Methods to Improve Cervical Cancer Screening in HIV+ Women
改善艾滋病毒女性宫颈癌筛查的分子方法
  • 批准号:
    8547940
  • 财政年份:
    2013
  • 资助金额:
    $ 72.37万
  • 项目类别:
Influence of Fasting Status and Specimen Processing Time on Adipokine Levels
禁食状态和标本处理时间对脂肪因子水平的影响
  • 批准号:
    8050302
  • 财政年份:
    2011
  • 资助金额:
    $ 72.37万
  • 项目类别:
Influence of Fasting Status and Specimen Processing Time on Adipokine Levels
禁食状态和标本处理时间对脂肪因子水平的影响
  • 批准号:
    8212193
  • 财政年份:
    2011
  • 资助金额:
    $ 72.37万
  • 项目类别:
Role of the Sex Hormones and Insulin/IGF-Axes in Endometrial Cancer Recurrence
性激素和胰岛素/IGF-轴在子宫内膜癌复发中的作用
  • 批准号:
    8271330
  • 财政年份:
    2009
  • 资助金额:
    $ 72.37万
  • 项目类别:
Role of the insulin/IGF-axis in incident CIN-2+
胰岛素/IGF轴在CIN-2事件中的作用
  • 批准号:
    7642830
  • 财政年份:
    2009
  • 资助金额:
    $ 72.37万
  • 项目类别:
Role of the insulin/IGF-axis in incident CIN-2+
胰岛素/IGF轴在CIN-2事件中的作用
  • 批准号:
    7835560
  • 财政年份:
    2009
  • 资助金额:
    $ 72.37万
  • 项目类别:
Role of the Sex Hormones and Insulin/IGF-Axes in Endometrial Cancer Recurrence
性激素和胰岛素/IGF-轴在子宫内膜癌复发中的作用
  • 批准号:
    8091318
  • 财政年份:
    2009
  • 资助金额:
    $ 72.37万
  • 项目类别:

相似国自然基金

E-cervix宫颈弹性成像评估双胎孕期宫颈机能的价值研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目

相似海外基金

Innovative Rapid Enabling, Affordable, point-of-Care HPV Self-Testing Strategy (I-REACH)
创新的快速、经济、即时护理 HPV 自检策略 (I-REACH)
  • 批准号:
    10648634
  • 财政年份:
    2023
  • 资助金额:
    $ 72.37万
  • 项目类别:
Feasibility of artesunate to improve HPV and cervical precancer treatment outcomes among HIV positive women in LMICs
青蒿琥酯改善中低收入国家 HIV 阳性女性 HPV 和宫颈癌前治疗结果的可行性
  • 批准号:
    10762866
  • 财政年份:
    2023
  • 资助金额:
    $ 72.37万
  • 项目类别:
Secondary Cervical Cancer Prevention of Vulnerable Women with HPV and HIV Co-infection in India
印度 HPV 和 HIV 合并感染的弱势女性的二级宫颈癌预防
  • 批准号:
    10761950
  • 财政年份:
    2023
  • 资助金额:
    $ 72.37万
  • 项目类别:
Real-world effectiveness of HPV vaccine in women living with HIV and its impact on cervical cancer screening accuracies
HPV 疫苗对 HIV 感染女性的真实有效性及其对宫颈癌筛查准确性的影响
  • 批准号:
    10682184
  • 财政年份:
    2023
  • 资助金额:
    $ 72.37万
  • 项目类别:
Single Visit Clinical Validation of ScreenFire, a Low-Cost HPV Test: Efficacy and Cost Effectiveness (SCALE)
ScreenFire(一种低成本 HPV 检测)的单次临床验证:功效和成本效益 (SCALE)
  • 批准号:
    10595668
  • 财政年份:
    2022
  • 资助金额:
    $ 72.37万
  • 项目类别:
Pathogenic role of human papillomavirus (HPV) DNA Integration and clonal expansion in cervical tumorigenesis
人乳头瘤病毒 (HPV) DNA 整合和克隆扩增在宫颈肿瘤发生中的致病作用
  • 批准号:
    10507371
  • 财政年份:
    2022
  • 资助金额:
    $ 72.37万
  • 项目类别:
Single Visit Clinical Validation of ScreenFire, a Low-Cost HPV Test: Efficacy and Cost Effectiveness (SCALE)
ScreenFire(一种低成本 HPV 检测)的单次临床验证:功效和成本效益 (SCALE)
  • 批准号:
    10340927
  • 财政年份:
    2022
  • 资助金额:
    $ 72.37万
  • 项目类别:
Pathogenic role of human papillomavirus (HPV) DNA Integration and clonal expansion in cervical tumorigenesis
人乳头瘤病毒 (HPV) DNA 整合和克隆扩增在宫颈肿瘤发生中的致病作用
  • 批准号:
    10700102
  • 财政年份:
    2022
  • 资助金额:
    $ 72.37万
  • 项目类别:
The effect of epigenetic DNA methylation on the progression of HPV-associated precancerous cervical lesions
表观遗传DNA甲基化对HPV相关宫颈癌前病变进展的影响
  • 批准号:
    10549767
  • 财政年份:
    2021
  • 资助金额:
    $ 72.37万
  • 项目类别:
Characterisation and harnessing the CD8+ Tissue Resident Memory T cell response in HPV-driven anal neoplasia.
HPV 驱动的肛门肿瘤中 CD8 组织驻留记忆 T 细胞反应的表征和利用。
  • 批准号:
    10256111
  • 财政年份:
    2021
  • 资助金额:
    $ 72.37万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了